[1] ZUK PA, ZHU M, MIZUNO H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7(2):211-228.
[2] ERICES A, CONGET P, MINGUELL JJ. Mesenchymal progenitor cells in human umbilical cord blood. Br J Haematol. 2000;109(1):235-242.
[3] FRIEDENSTEIN AJ, PETRAKOVA KV, KUROLESOVA AI, et al. Heterotopic of bone marrow. Analysis of precursor cells for osteogenic and hematopoietic tissues. Transplantation. 1968;6(2):230-247.
[4] 施彦龙,李应福,谢兴文,等.BMP/Smads、OPG/RANK/RANKL信号通路与骨质疏松关系的研究进展[J].中国骨质疏松杂志,2020, 26(4):600-604.
[5] JAMES AW. Review of Signaling Pathways Governing MSC Osteogenic and Adipogenic Differentiation. Scientifica (Cairo). 2013;2013:684736.
[6] 刘小钰,宋敏,蒋林博,等.补骨脂活性成分对骨质疏松相关信号通路影响的研究概况[J].中国骨质疏松杂志,2017,23(6):831-836.
[7] WU M, CHEN G, LI YP. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4:16009.
[8] CHANG C. Agonists and Antagonists of TGF-β Family Ligands. Cold Spring Harb Perspect Biol. 2016;8(8):a021923.
[9] CUI ZK, SUN JA, BALJON JJ, et al. Simultaneous delivery of hydrophobic small molecules and siRNA using Sterosomes to direct mesenchymal stem cell differentiation for bone repair. Acta Biomater. 2017;58: 214-224.
[10] CHEN C, ULUDAĞ H, WANG Z, et al. Noggin suppression decreases BMP-2-induced osteogenesis of human bone marrow-derived mesenchymal stem cells in vitro. J Cell Biochem. 2012;113(12): 3672-3680.
[11] LIU T, LI B, ZHENG XF, et al. Chordin-Like 1 Improves Osteogenesis of Bone Marrow Mesenchymal Stem Cells Through Enhancing BMP4-SMAD Pathway. Front Endocrinol (Lausanne). 2019;10:360.
[12] GAUR T, LENGNER CJ, HOVHANNISYAN H, et al. Canonical WNT signaling promotes osteogenesis by directly stimulating Runx2 gene expression. J Biol Chem. 2005;280(39):33132-33140.
[13] CAWTHORN WP, BREE AJ, YAO Y, et al. Wnt6, Wnt10a and Wnt10b inhibit adipogenesis and stimulate osteoblastogenesis through a β-catenin-dependent mechanism. Bone. 2012;50(2):477-489.
[14] GONG Y, SLEE RB, FUKAI N, et al. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell. 2001;107(4):513-523.
[15] BOYDEN LM, MAO J, BELSKY J, et al. High bone density due to a mutation in LDL-receptor-related protein 5. N Engl J Med. 2002; 346(20):1513-1521.
[16] WANG T, LI J, ZHOU GQ, et al. Specific Deletion of β-Catenin in Col2-Expressing Cells Leads to Defects in Epiphyseal Bone. Int J Biol Sci. 2017;13(12):1540-1546.
[17] WANG Y, LI YP, PAULSON C, et al. Wnt and the Wnt signaling pathway in bone development and disease. Front Biosci (Landmark Ed). 2014; 19:379-407.
[18] ESEN E, CHEN J, KARNER CM, et al. WNT-LRP5 signaling induces Warburg effect through mTORC2 activation during osteoblast differentiation. Cell Metab. 2013;17(5):745-755.
[19] KARNER CM, ESEN E, OKUNADE AL, et al. Increased glutamine catabolism mediates bone anabolism in response to WNT signaling. J Clin Invest. 2015;125(2):551-562.
[20] KOPAN R, ILAGAN MX. The canonical Notch signaling pathway: unfolding the activation mechanism. Cell. 2009;137(2):216-233.
[21] SIMPSON MA, IRVING MD, ASILMAZ E, et al. Mutations in NOTCH2 cause Hajdu-Cheney syndrome, a disorder of severe and progressive bone loss. Nat Genet. 2011;43(4):303-305.
[22] LEE SY, LONG F. Notch signaling suppresses glucose metabolism in mesenchymal progenitors to restrict osteoblast differentiation. J Clin Invest. 2018;128(12):5573-5586.
[23] LONG F. Building strong bones: molecular regulation of the osteoblast lineage. Nat Rev Mol Cell Biol. 2011;13(1):27-38.
[24] KARSENTY G, KRONENBERG HM, SETTEMBRE C. Genetic control of bone formation. Annu Rev Cell Dev Biol. 2009;25:629-648.
[25] WEI J, SHIMAZU J, MAKINISTOGLU MP, et al. Glucose Uptake and Runx2 Synergize to Orchestrate Osteoblast Differentiation and Bone Formation. Cell. 2015;161(7):1576-1591.
[26] CHEN Q, SHOU P, ZHENG C, et al. Fate decision of mesenchymal stem cells: adipocytes or osteoblasts? Cell Death Differ. 2016;23(7): 1128-1139.
[27] ZHU W, HE X, HUA Y, et al. The E3 ubiquitin ligase WWP2 facilitates RUNX2 protein transactivation in a mono-ubiquitination manner during osteogenic differentiation. J Biol Chem. 2017;292(27):11178-11188.
[28] KUMAR Y, KAPOOR I, KHAN K, et al. Withdrawal: E3 ubiquitin ligase Fbw7 negatively regulates osteoblast differentiation by targeting Runx2 for degradation. J Biol Chem. 2019;294(1):68.
[29] VISAVADIYA NP, KEASEY MP, RAZSKAZOVSKIY V, et al. Erratum to: Integrin-FAK signaling rapidly and potently promotes mitochondrial function through STAT3. Cell Commun Signal. 2017;15(1):11.
[30] GURI Y, COLOMBI M, DAZERT E, et al. mTORC2 Promotes Tumorigenesis via Lipid Synthesis. Cancer Cell. 2017;32(6):807-823.
[31] ZHENG W, GU X, SUN X, et al. FAK mediates BMP9-induced osteogenic differentiation via Wnt and MAPK signaling pathway in synovial mesenchymal stem cells. Artif Cells Nanomed Biotechnol. 2019;47(1):2641-2649.
[32] HUANG G, LI F, ZHAO X, et al. Functional and Biomimetic Materials for Engineering of the Three-Dimensional Cell Microenvironment. Chem Rev. 2017;117(20):12764-12850.
[33] JIANG Y, WU W, JIAO G, et al. LncRNA SNHG1 modulates p38 MAPK pathway through Nedd4 and thus inhibits osteogenic differentiation of bone marrow mesenchymal stem cells. Life Sci. 2019;228:208-214.
[34] ZHANG J, TAO Z, WANG Y. Long non‑coding RNA DANCR regulates the proliferation and osteogenic differentiation of human bone-derived marrow mesenchymal stem cells via the p38 MAPK pathway. Int J Mol Med. 2018;41(1):213-219.
[35] ZHUANG W, GE X, YANG S, et al. Upregulation of lncRNA MEG3 Promotes Osteogenic Differentiation of Mesenchymal Stem Cells From Multiple Myeloma Patients By Targeting BMP4 Transcription. Stem Cells. 2015;33(6):1985-1997.
[36] TANG S, XIE Z, WANG P, et al. LncRNA-OG Promotes the Osteogenic Differentiation of Bone Marrow-Derived Mesenchymal Stem Cells Under the Regulation of hnRNPK. Stem Cells. 2019;37(2):270-283.
[37] JIA Q, JIANG W, NI L. Down-regulated non-coding RNA (lncRNA-ANCR) promotes osteogenic differentiation of periodontal ligament stem cells. Arch Oral Biol. 2015;60(2):234-241.
[38] GAO Y, XIAO F, WANG C, et al. Long noncoding RNA MALAT1 promotes osterix expression to regulate osteogenic differentiation by targeting miRNA-143 in human bone marrow-derived mesenchymal stem cells. J Cell Biochem. 2018;119(8):6986-6996.
[39] DING W, LI J, SINGH J, et al. miR-30e targets IGF2-regulated osteogenesis in bone marrow-derived mesenchymal stem cells, aortic smooth muscle cells, and ApoE-/- mice. Cardiovasc Res. 2015;106(1): 131-142.
[40] LI CJ, CHENG P, LIANG MK, et al. MicroRNA-188 regulates age-related switch between osteoblast and adipocyte differentiation. J Clin Invest. 2015;125(4):1509-1522.
[41] WANG CG, LIAO Z, XIAO H, et al. LncRNA KCNQ1OT1 promoted BMP2 expression to regulate osteogenic differentiation by sponging miRNA-214. Exp Mol Pathol. 2019;107:77-84.
[42] DENG Y, WU S, ZHOU H, et al. Effects of a miR-31, Runx2, and Satb2 regulatory loop on the osteogenic differentiation of bone mesenchymal stem cells. Stem Cells Dev. 2013;22(16):2278-2286.
[43] WANG JL, WEI X, WANG AG, et al. KCNQ1OT1 regulates osteogenic differentiation of hBMSC by miR-320a/Smad5 axis. Eur Rev Med Pharmacol Sci. 2020;24(6):2843-2854.
[44] YANG C, LIU X, ZHAO K, et al. miRNA-21 promotes osteogenesis via the PTEN/PI3K/Akt/HIF-1α pathway and enhances bone regeneration in critical size defects. Stem Cell Res Ther. 2019;10(1):65.
[45] TANG QQ, LANE MD. Adipogenesis: from stem cell to adipocyte. Annu Rev Biochem. 2012;81:715-736.
[46] ZUR NIEDEN NI, KEMPKA G, RANCOURT DE, et al. Induction of chondro-, osteo- and adipogenesis in embryonic stem cells by bone morphogenetic protein-2: effect of cofactors on differentiating lineages. BMC Dev Biol. 2005;5:1.
[47] XU B, JU Y, SONG G. Role of p38, ERK1/2, focal adhesion kinase, RhoA/ROCK and cytoskeleton in the adipogenesis of human mesenchymal stem cells. J Biosci Bioeng. 2014;117(5):624-631.
[48] KAWAI M, MUSHIAKE S, BESSHO K, et al. Wnt/Lrp/beta-catenin signaling suppresses adipogenesis by inhibiting mutual activation of PPARgamma and C/EBPalpha. Biochem Biophys Res Commun. 2007; 363(2):276-282.
[49] MURUGANANDAN S, ROMAN AA, SINAL CJ. Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program. Cell Mol Life Sci. 2009;66(2):236-253.
[50] ZHOU Y, SONG T, PENG J, et al. SIRT1 suppresses adipogenesis by activating Wnt/β-catenin signaling in vivo and in vitro. Oncotarget. 2016;7(47):77707-77720.
[51] BENNETT CN, LONGO KA, WRIGHT WS, et al. Regulation of osteoblastogenesis and bone mass by Wnt10b. Proc Natl Acad Sci U S A. 2005;102(9):3324-3329.
[52] NEELS JG, GRIMALDI PA. Physiological functions of peroxisome proliferator-activated receptor β. Physiol Rev. 2014;94(3):795-858.
[53] TONTONOZ P, SPIEGELMAN BM. Fat and beyond: the diverse biology of PPARgamma. Annu Rev Biochem. 2008;77:289-312.
[54] SCHUPP M, LAZAR MA. Fingered for a fat fate. Cell Metab. 2010;11(4): 244-245.
[55] WALKEY CJ, SPIEGELMAN BM. A functional peroxisome proliferator-activated receptor-gamma ligand-binding domain is not required for adipogenesis. J Biol Chem. 2008;283(36):24290-24294.
[56] GU C, XU Y, ZHANG S, et al. miR-27a attenuates adipogenesis and promotes osteogenesis in steroid-induced rat BMSCs by targeting PPARγ and GREM1. Sci Rep. 2016;6:38491.
[57] WANG Y, ZHAO L, SMAS C, et al. Pref-1 interacts with fibronectin to inhibit adipocyte differentiation. Mol Cell Biol. 2010;30(14):3480-3492.
[58] RAUCH A, HAAKONSSON AK, MADSEN JGS, et al. Osteogenesis depends on commissioning of a network of stem cell transcription factors that act as repressors of adipogenesis. Nat Genet. 2019;51(4):716-727.
[59] BORK S, HORN P, CASTOLDI M, et al. Adipogenic differentiation of human mesenchymal stromal cells is down-regulated by microRNA-369-5p and up-regulated by microRNA-371. J Cell Physiol. 2011;226(9): 2226-2234.
[60] SUN J, WANG Y, LI Y, et al. Downregulation of PPARγ by miR-548d-5p suppresses the adipogenic differentiation of human bone marrow mesenchymal stem cells and enhances their osteogenic potential. J Transl Med. 2014;12:168.
[61] HAMAM D, ALI D, VISHNUBALAJI R, et al. microRNA-320/RUNX2 axis regulates adipocytic differentiation of human mesenchymal (skeletal) stem cells. Cell Death Dis. 2014;5(10):e1499.
[62] KIM YJ, HWANG SJ, BAE YC, et al. MiR-21 regulates adipogenic differentiation through the modulation of TGF-beta signaling in mesenchymal stem cells derived from human adipose tissue. Stem Cells. 2009;27(12):3093-3102.
[63] LIU Y, ZHANG ZC, QIAN SW, et al. MicroRNA-140 promotes adipocyte lineage commitment of C3H10T1/2 pluripotent stem cells via targeting osteopetrosis-associated transmembrane protein 1. J Biol Chem. 2013;288(12):8222-8230.
[64] 汪建样,吴次虎,殷嫦嫦,等.Wnt信号通路调控干细胞成软骨分化[J].中国细胞生物学学报,2015,37(11):1554-1559.
[65] AKIYAMA H, LYONS JP, MORI-AKIYAMA Y, et al. Interactions between Sox9 and beta-catenin control chondrocyte differentiation. Genes Dev. 2004;18(9):1072-1087.
[66] JIN EJ, LEE SY, CHOI YA, et al. BMP-2-enhanced chondrogenesis involves p38 MAPK-mediated down-regulation of Wnt-7a pathway. Mol Cells. 2006;22(3):353-359.
[67] CHURCH V, NOHNO T, LINKER C, et al. Wnt regulation of chondrocyte differentiation. J Cell Sci. 2002;115(Pt 24):4809-4818.
[68] QU F, WANG J, XU N, et al. WNT3A modulates chondrogenesis via canonical and non-canonical Wnt pathways in MSCs. Front Biosci (Landmark Ed). 2013;18:493-503.
[69] 刘刚,张磊,扶世杰.Notch信号通路在软骨细胞分化过程中的作用[J].医学研究生学报,2016,29(10):1111-1115.
[70] TIAN Y, XU Y, FU Q, et al. Notch inhibits chondrogenic differentiation of mesenchymal progenitor cells by targeting Twist1. Mol Cell Endocrinol. 2015;403:30-38.
[71] ZANOTTI S, SMERDEL-RAMOYA A, CANALIS E. Reciprocal regulation of Notch and nuclear factor of activated T-cells (NFAT) c1 transactivation in osteoblasts. J Biol Chem. 2011;286(6):4576-4588.
[72] KAMEI N, KWON SM, ISHIKAWA M, et al. Endothelial progenitor cells promote astrogliosis following spinal cord injury through Jagged1-dependent Notch signaling. J Neurotrauma. 2012;29(9):1758-1769.
[73] DONG Y, JESSE AM, KOHN A, et al. RBPjkappa-dependent Notch signaling regulates mesenchymal progenitor cell proliferation and differentiation during skeletal development. Development. 2010;137(9):1461-1471.
[74] CAO L, YANG F, LIU G, et al. The promotion of cartilage defect repair using adenovirus mediated Sox9 gene transfer of rabbit bone marrow mesenchymal stem cells. Biomaterials. 2011;32(16):3910-3920.
[75] 吕学敏,杨庆铭,邓廉夫.调控软骨生成和软骨内骨化的转录因子及其相关机制研究进展[J].中国矫形外科杂志,2004,12(3):268-270.
[76] TENCEROVA M, RENDINA-RUEDY E, NEESS D, et al. Metabolic programming determines the lineage-differentiation fate of murine bone marrow stromal progenitor cells. Bone Res. 2019;7:35.
[77] LI Q, GAO Z, CHEN Y, et al. The role of mitochondria in osteogenic, adipogenic and chondrogenic differentiation of mesenchymal stem cells. Protein Cell. 2017;8(6):439-445.
[78] LIU H, ZHONG L, YUAN T, et al. MicroRNA-155 inhibits the osteogenic differentiation of mesenchymal stem cells induced by BMP9 via downregulation of BMP signaling pathway. Int J Mol Med. 2018;41(6): 3379-3393.
[79] HUANG H, DOU L, SONG J, et al. CBFA2T2 is required for BMP-2-induced osteogenic differentiation of mesenchymal stem cells. Biochem Biophys Res Commun. 2018;496(4):1095-1101.
[80] ALMALKI SG, AGRAWAL DK. Key transcription factors in the differentiation of mesenchymal stem cells. Differentiation. 2016;92(1-2):41-51.
[81] LEE WC, GUNTUR AR, LONG F, et al. Energy Metabolism of the Osteoblast: Implications for Osteoporosis. Endocr Rev. 2017;38(3): 255-266.
[82] MALEKZADEH BÖ, ERLANDSSON MC, TENGVALL P, et al. Effects of implant-delivered insulin on bone formation in osteoporotic rats. J Biomed Mater Res A. 2018;106(9):2472-2480.
[83] AGHEBATI-MALEKI L, DOLATI S, ZANDI R, et al. Prospect of mesenchymal stem cells in therapy of osteoporosis: A review. J Cell Physiol. 2019;234(6):8570-8578.
[84] HU L, YIN C, ZHAO F, et al. Mesenchymal Stem Cells: Cell Fate Decision to Osteoblast or Adipocyte and Application in Osteoporosis Treatment. Int J Mol Sci. 2018;19(2):360.
[85] CHO SW, SUN HJ, YANG JY, et al. Transplantation of mesenchymal stem cells overexpressing RANK-Fc or CXCR4 prevents bone loss in ovariectomized mice. Mol Ther. 2009;17(11):1979-1987.
[86] TZOUVELEKIS A, TOONKEL R, KARAMPITSAKOS T, et al. Mesenchymal Stem Cells for the Treatment of Idiopathic Pulmonary Fibrosis. Front Med (Lausanne). 2018;5:142.
[87] MANSOURI N, WILLIS GR, FERNANDEZ-GONZALEZ A, et al. Mesenchymal stromal cell exosomes prevent and revert experimental pulmonary fibrosis through modulation of monocyte phenotypes. JCI Insight. 2019;4(21):e128060. |